earnings
saveAbbVie Inc. earnings
community read0 votes
Anticipated earnings call for AbbVie Inc. ($ABBV).
view source ↗Data sources
Found something off?
same company · ±60 days · 6
- phase 1 2 completionblinatumomab: AbbVie Inc — blinatumomab (Phase I/II Trial Completion)Apr 30, 2026
- phase 1 2 completionvenetoclax: AbbVie Inc — venetoclax (Phase I/II Trial Completion)Apr 30, 2026
- grantUNIV OF NORTH CAROLINA CHAPEL HILL — A Trial of Upadacitinib for Non-responsive Eosinophilic esophagitis (ATUNE)Apr 6, 2026
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026
🐶 often sniffed alongside
top 8- tagApproval168 co-mentions · 84 sources
- drugHUMIRA122 co-mentions · 61 sources
- drugadalimumab122 co-mentions · 61 sources
- drugABRILADA61 co-mentions · 61 sources
- drugYUSIMRY61 co-mentions · 61 sources
- drugAMJEVITA61 co-mentions · 61 sources
- drugSKYRIZI46 co-mentions · 23 sources
- drugrisankizumab46 co-mentions · 23 sources
comments(0)
5-min edit window · permanent after that